| Polybrominated diphenyl ether (PBDE) flame retardants: environmental contamination, human body burden and potential adverse health effects LG Costa, G Giordano, S Tagliaferri, A Caglieri, A Mutti Acta Biomed 79 (3), 172-183, 2008 | 372 | 2008 |
| The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients N Giuliani, F Morandi, S Tagliaferri, M Lazzaretti, S Bonomini, M Crugnola, ... Blood, The Journal of the American Society of Hematology 110 (1), 334-338, 2007 | 304 | 2007 |
| A mechanistic view of polybrominated diphenyl ether (PBDE) developmental neurotoxicity LG Costa, R de Laat, S Tagliaferri, C Pellacani Toxicology letters 230 (2), 282-294, 2014 | 262 | 2014 |
| Antiglycative and neuroprotective activity of colon‐derived polyphenol catabolites E Verzelloni, C Pellacani, D Tagliazucchi, S Tagliaferri, L Calani, ... Molecular Nutrition & Food Research 55 (S1), S35-S43, 2011 | 235 | 2011 |
| The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible … S Colla, S Tagliaferri, F Morandi, P Lunghi, G Donofrio, D Martorana, ... Blood, The Journal of the American Society of Hematology 110 (13), 4464-4475, 2007 | 169 | 2007 |
| Low concentrations of the brominated flame retardants BDE-47 and BDE-99 induce synergistic oxidative stress-mediated neurotoxicity in human neuroblastoma cells S Tagliaferri, A Caglieri, M Goldoni, S Pinelli, R Alinovi, D Poli, ... Toxicology in Vitro 24 (1), 116-122, 2010 | 134 | 2010 |
| Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment N Giuliani, F Morandi, S Tagliaferri, M Lazzaretti, G Donofrio, S Bonomini, ... Cancer research 67 (16), 7665-7674, 2007 | 128 | 2007 |
| The risk of dysphagia is associated with malnutrition and poor functional outcomes in a large population of outpatient older individuals S Tagliaferri, F Lauretani, G Pelá, T Meschi, M Maggio Clinical nutrition 38 (6), 2684-2689, 2019 | 124 | 2019 |
| Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines S La Monica, M Galetti, RR Alfieri, A Cavazzoni, A Ardizzoni, M Tiseo, ... Biochemical pharmacology 78 (5), 460-468, 2009 | 104 | 2009 |
| CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival N Giuliani, S Bonomini, P Romagnani, M Lazzaretti, F Morandi, S Colla, ... Haematologica 91 (11), 1489-1497, 2006 | 103 | 2006 |
| The controversial role of vitamin D as an antioxidant: results from randomised controlled trials S Tagliaferri, D Porri, R De Giuseppe, M Manuelli, F Alessio, H Cena Nutrition research reviews 32 (1), 99-105, 2019 | 98 | 2019 |
| Sex-related differences in long-COVID-19 syndrome G Pelà, M Goldoni, E Solinas, C Cavalli, S Tagliaferri, S Ranzieri, ... Journal of Women's Health 31 (5), 620-630, 2022 | 83 | 2022 |
| The gut-muscle axis in older subjects with low muscle mass and performance: a proof of concept study exploring fecal microbiota composition and function with shotgun … A Ticinesi, L Mancabelli, S Tagliaferri, A Nouvenne, C Milani, D Del Rio, ... International journal of molecular sciences 21 (23), 8946, 2020 | 79 | 2020 |
| Adverse events of proton pump inhibitors: potential mechanisms A Corsonello, F Lattanzio, S Bustacchini, S Garasto, A Cozza, R Schepisi, ... Current drug metabolism 19 (2), 142-154, 2018 | 66 | 2018 |
| Assessment and treatment of older individuals with COVID-19 multi-system disease: clinical and ethical implications F Lauretani, G Ravazzoni, MF Roberti, Y Longobucco, E Adorni, M Grossi, ... Acta Bio Medica: Atenei Parmensis 91 (2), 150, 2020 | 55 | 2020 |
| Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patients N Giuliani, F Morandi, S Tagliaferri, S Colla, S Bonomini, G Sammarelli, ... Blood 107 (2), 841-842, 2006 | 55 | 2006 |
| Age‐related alterations in muscle architecture are a signature of sarcopenia: the ultrasound sarcopenia index M Narici, J McPhee, M Conte, MV Franchi, K Mitchell, S Tagliaferri, ... Journal of cachexia, sarcopenia and muscle 12 (4), 973-982, 2021 | 52 | 2021 |
| Synergistic interactions between PBDEs and PCBs in human neuroblastoma cells C Pellacani, S Tagliaferri, A Caglieri, M Goldoni, G Giordano, A Mutti, ... Environmental toxicology 29 (4), 418-427, 2014 | 50 | 2014 |
| The sarcopenia and physical frailty in older people: multi-component treatment strategies (SPRINTT) project: description and feasibility of a nutrition intervention in … SK Jyväkorpi, A Ramel, TE Strandberg, K Piotrowicz, ... European geriatric medicine 12, 303-312, 2021 | 36 | 2021 |
| Phomopsins: An overview of phytopathological and chemical aspects, toxicity, analysis and occurrence P Battilani, A Gualla, C Dall'Asta, C Pellacani, G Galaverna, P Giorni, ... World Mycotoxin Journal 4 (4), 345-359, 2011 | 32 | 2011 |
